Cargando…

Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer

Currently, there is no consensus about the use of adjuvant chemotherapy for patients with stage II colorectal cancer. Here, we aimed to identify and validate a prognostic mRNA expression signature for the stratification of patients with stage II colorectal cancer according to their risk for relapse....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rokavec, Matjaz, Özcan, Elif, Neumann, Jens, Hermeking, Heiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467603/ https://www.ncbi.nlm.nih.gov/pubmed/37654625 http://dx.doi.org/10.1158/2767-9764.CRC-22-0489

Ejemplares similares

Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression
por: Rokavec, Matjaz, et al.
Publicado: (2017)

Nidogen-1/NID1 Function and Regulation during Progression and Metastasis of Colorectal Cancer
por: Rokavec, Matjaz, et al.
Publicado: (2023)

Squalene epoxidase/SQLE is a candidate target for treatment of colorectal cancers with p53 mutation and elevated c-MYC expression
por: Du, Yuyun, et al.
Publicado: (2023)

Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis
por: Rokavec, Matjaz, et al.
Publicado: (2019)

Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis
por: Liu, Chunfeng, et al.
Publicado: (2023)

Salicylate induces AMPK and inhibits c-MYC to activate a NRF2/ARE/miR-34a/b/c cascade resulting in suppression of colorectal cancer metastasis
por: Liu, Chunfeng, et al.
Publicado: (2023)

Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop
por: Li, Huihui, et al.
Publicado: (2015)

Meta-analysis of miR-34 target mRNAs using an integrative online application
por: Rokavec, Matjaz, et al.
Publicado: (2022)

The p53/microRNA connection in gastrointestinal cancer
por: Rokavec, Matjaz, et al.
Publicado: (2014)

Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer
por: Shi, Xiaolong, et al.
Publicado: (2020)

miR-34a and IRE1A/XBP-1(S) Form a Double-Negative Feedback Loop to Regulate Hypoxia-Induced EMT, Metastasis, Chemo-Resistance and Autophagy
por: Bouznad, Nassim, et al.
Publicado: (2023)

AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG/miR-22-3p
por: Chou, Jinjiang, et al.
Publicado: (2022)

SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis
por: Loevenich, Leon P., et al.
Publicado: (2022)

Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer
por: Boos, Sophie L., et al.
Publicado: (2021)

Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer
por: Feng, Junlan, et al.
Publicado: (2021)

The transient and constitutive inflammatory signaling in tumorigenesis
por: Rokavec, Matjaz, et al.
Publicado: (2012)

AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
por: Jackstadt, Rene, et al.
Publicado: (2013)

Stage II colorectal cancer: lack of prognostic model
por: Buhmeida, Abdelbaset
Publicado: (2007)

Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer
por: Dietinger, Vanessa, et al.
Publicado: (2020)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients
por: Shi, Mingguang, et al.
Publicado: (2016)

CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34
por: Huang, Zekai, et al.
Publicado: (2023)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Microsatellite Instability, KRAS Mutations and Cellular Distribution of TRAIL-Receptors in Early Stage Colorectal Cancer
por: Kriegl, Lydia, et al.
Publicado: (2012)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment
por: Boyaval, Fanny, et al.
Publicado: (2021)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma
por: Guo, Tianhua, et al.
Publicado: (2014)

Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2017)

The prognostic influence of tumour budding in Western patients with stage II colorectal cancer
por: Canguçu, Augusto Leite, et al.
Publicado: (2020)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

c-MYC and SIRT1 locked in a vicious cycle
por: Menssen, Antje, et al.
Publicado: (2012)

AP4 is required for mitogen- and c-MYC-induced cell cycle progression
por: Jackstadt, Rene, et al.
Publicado: (2014)

p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3
por: Hünten, Sabine, et al.
Publicado: (2015)

Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer
por: Qu, Ailin, et al.
Publicado: (2023)

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer
por: Liu, Yue, et al.
Publicado: (2014)

GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer
por: Zhao, Zhixun, et al.
Publicado: (2018)

Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients
por: Dimitriou, Nikoletta, et al.
Publicado: (2018)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
por: Goeman, Frauke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9o4d6nnp6g1t44b421m9sgo30e